The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density

Journal of Molecular Endocrinology

Volumn 42, Issue 3, 2009, Pages 239-247

  Mencej Bedrač, Simona ^a   Preželi, Janez ^b   Kocjan, Tomaž ^b   Teskač, Karmen ^a   Ostanek, Barbara ^a   Šmelcer, Mojca ^a   Marc, Janja ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; GUANINE; OSTEOPROTEGERIN; THYMINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR SUPERFAMILY MEMBER 11; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; FEMALE; FEMUR NECK; GENE FUNCTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; POSTMENOPAUSE OSTEOPOROSIS; PREMENOPAUSE; PRIORITY JOURNAL; GENETICS; MIDDLE AGED; PHYSIOLOGY; POSTMENOPAUSE;

ADULT; AGED; BONE DENSITY; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPROTEGERIN; POLYMORPHISM, GENETIC; POSTMENOPAUSE; PREMENOPAUSE; RECEPTORS, CALCITRIOL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 64549106604     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-08-0108     Document Type: Article

References (31)

1. Arko B, Prezelj J, Kocijancic A, Komel R & Marc J 2005 Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women. Maturitas 51 270-279.
2. Baldock PA, Thomas GP, Hodge JM, Baker SUK, Dressel U, O'Loughlin PD, Nicholson GC, Briffa KH, Eisman JA & Gardiner EM 2006 Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast. Journal of Bone and Mineral Research 21 1618-1626.
3. Choi JY, Shin A, Park SK, Chung HW, Cho SI, Shin CS, Kim H, Lee K, Lee KH, Kang C et al. 2005 Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women. Calcified Tissue International 77 152-159.
4. Cooper GS & Umbach DM 1996 Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis Journal of Bone and Mineral Research 11 1841-1849.
5. Fang Y, van Meurs JB, d'Alesio A, Jhamai M, Zhao H, Rivadeneira F, Hofman A, van Leeuwen JPT, Jehan F, Pols HAP et al. 2005 Promoter and 3′-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam study. American Journal of Human Genetics 77 807-823.
6. García-Unzueta MT, Riancho JA, Zarrabeitia MT, Sañudo C, Berja A, Valero C, Pesquera C, Paule B, González-Macías J & Amado JA 2008 Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density. Hormone and Metabolic Research 40 219-224.
7. Gong G, Stern H, Cheng S, Fong N, Mordeson J, Deng H & Recker R 1999 The association of bone mineral density with vitamin D receptor polymorphisms. Osteoporosis International 9 55-64.
8. Hsu YH, Niu T, Terwedow HA, Xu X, Feng Y, Li Z, Brian JD, Rosen CJ, Laird N & Xu X 2006 Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men. Human Genetics 118 568-577.
9. Kim S, Yamazaki M, Zella LA, Shevde NK & Pike JW 2006 Activation of receptor activator of NF-κB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers. Molecular and Cellular Biology 26 6469-6486.
10. Kim JG, Kim JH, Kim JY, Ku SY, Jee BC, Suh CS, Kim SH & Choi YM 2007 Association between osteoprotegerin (OPG), receptor activator of nuclear factor kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Menopause 14 913-918.
11. Kitazawa R, Kitazawa S & Maeda S 1999 Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene. Biochimica et Biophysica Acta 1445 134-141.
12. 3 rapidly regulates the mouse osteoprotegerin gene through dual pathways. Journal of Bone and Mineral Research 19 1411-1419.
13. Langdahl BL, Carstens M, Stenkjaer L & Ericksen EF 2002 Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. Journal of Bone and Mineral Research 17 1245-1255.
14. Marc J, Prezelj J, Komel R & Kocijancic A 2000 Association of vitamin D receptor gene polymorphism with bone mineral density in Slovenian postmenopausal women. Gynecological Endocrinology 14 60-64.
15. Mencej S, Prezelj J, Kocijancic A, Ostanek B & Marc J 2006 Association of TNFSF11 gene promoter polymorphisms with bone mineral density in postmenopausal women. Maturitas 55 219-236.
16. Mencej S, Albagha OME, Prezelj J, Kocjan T & Marc J 2008 Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis. Journal of Molecular Endocrinology 40 273-279.
17. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN & Eisman JA 1994 Prediction of bone density from vitamin D receptor alleles. Nature 367 284-287.
18. Mueller JC 2004 Linkage disequilibrium for different scales and applications. Briefings in Bioinformatics 5 355-364.
19. Nerenz RD, Martowicz ML & Pike JW 2008 An enhancer 20 kilobases upstream of the human receptor activator of NF-κB ligand gene mediates dominant activation by 1,25-dihydroxyvitamin D3. Molecular Endocrinology 22 1044-1056.
20. Ralston SH & de Crombrugghe B 2006 Genetic regulation of bone mass and susceptibility to osteoporosis. Genes and Development 20 2492-2506.
21. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG, Andrew T, Falchi M, Gwilliam R, Ahmadi KR et al. 2008 Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371 1505-1512.
22. Shepherd JA, Lu Y, Wilson K, Fuerst T, Genant H, Hangartner TN, Wilson C, Hans D, Leib ES & International Society for Clinical Densitometry Committee on Standards of Bone Measurement 2006 Cross-calibration and minimum precision standards for dual-energy X-ray absorptiometry: the 2005 ISCD Official Positions. Journal of Clinical Densitometry 9 31-36.
23. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Center JR, Nguyen TV et al. 2008 Multiple genetic loci for bone mineral density and fractures. New England Journal of Medicine 358 2355-2365.
24. Thakkinstian A, d'Este C, Eisman J, Nguyen T & Attia J 2004 Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. Journal of Bone and Mineral Research 19 419-428.
25. Ueland T, Bollerslev J, Wilson SG, Dick IM, Islam FM, Mullin BH, Devine A & Prince RL 2007 No association between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women. Bone 40 175-181.
26. Uitterlinden AG, Ralston SH, Brandi ML, Carey AH, Grinberg D, Langdahl BL, Lips P, Lorenc R, Obermayer-Pietsch B, Reeve J et al. 2006 The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Annals of Internal Medicine 145 255-264.
27. World Health Organisation 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO Study Group. World Health Organization Technical Report Series 843 1-129.
28. Wynne F, Drummond F, O'Sullivan K, Daly M, Shanahan F, Molloy MG & Quane KA 2002 Investigation of the genetic influence of the OPG, VDR (FokI), and COLIA1 Sp1 polymorphisms on BMD in the Irish population. Calcified Tissue International 71 26-35.
29. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Goto M, Mochizuki SI, Tsuda E, Morinaga T, Udagawa N et al. 1999 A novel molecular mechanism modulating osteoclast differentiation and function. Bone 25 109-113.
30. Zhao HY, Liu JM, Ning G, Zhao YJ, Zhang LZ, Sun LH, Xu MY, Uitterlinden AG & Chen JL 2005 The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. Osteoporosis International 16 1519-1524.
31. Zintzaras E, Rodopoulou P & Koukoulis NG 2006 BsmI, TaqI, ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and the risk of osteoporosis: a meta-analysis. Disease Markers 22 317-326.